Along with the news of the abrupt resignation of Pfizer's former CEO Jeffrey Kindler, the drug giant has now been dragged into the red-hot WikiLeaks controversy. Oh boy, buckle your seatbelts ...
December 13, 2010 at 12:00 AM
1 minute read
Former Pfizer Inc. CEO Jeffrey Kindler’s abrupt resignation on Dec. 5 came just in time to give the feds what they wanted: A new leadership structure at the drug giant.
While accepting Kindler’s resignation, the board of directors suddenly reversed its longstanding stance on corporate structure — announcing that Kindler’s replacement would hold the CEO job only, and that a new chairman of the board would be named later.
Presented by BigVoodoo
General Counsel Summit is the premier event for in-house counsel, hosting esteemed legal minds from all sectors of the economy.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Predictive reporting, trend analysis, peer guidance and a practical playbook to help genetal counsels succeed in their increasingly high stakes roles as risk managers and corporate strategists
